ABSA International
ABSA International

Resources with keywords: covid-19



Isolation and Precautions for People with COVID-19 (Website, Regulatory)
CDC

From CDC: A tool to help you determine if you need to isolate or take other steps to prevent spreading COVID-19.

SARS-CoV-2 Rebound With and Without Use of COVID-19 Oral Antivirals (Website)
CDC/MMWR
22 December 2023

Smith DJ, Lambrou A, Patel P
After anti-viral treatment, no consistent association between treatment and rebound was identified.

Remission of severe forms of long COVID following monoclonal antibody (MCA) infusions: A report of signal index cases and call for targeted research (Website)
ScienceDirect
4 October 2023

Scheppke KA, Pepe PE, et al.
Three individuals with long Covid experienced full remission within a week after monoclonal antibody infusion.

When Will the Next COVID Vaccine Be Available, and Who Should Get It? (NEW 9/13, Website)
Scientific American
1 September 2023

Includes info on when the vaccine may be approved and who will benefit most from a booster.

Workplace Safety Plan (Document, Regulatory)
U.S. Department of Labor (DOL)
1 September 2024
keywords: covid-19, workplace
Update on SARS CoV-2 Variant BA.2.86 (NEW 9/13, Website, Regulatory)
CDC
30 August 2023

CDC is tracking a new SARS-CoV-2 variant called BA.2.86 (Pirola) and working to better understand its potential impact on public health.

New standard on cutting risk of infectious aerosol spread sets high bar for building ventilation but is work in progress (NEW 9/13, Website)
CIDRAP
15 August 2023

The first-ever ASHRAE standard on reducing the risk of indoor infectious aerosol transmission sets new targets for building operators in terms of air system design, installation, operation, and maintenance.

ASHRAE Publishes Standard 241, Control of Infectious Aerosols (NEW 9/13, Website)
ASHRAE
7 July 2023

ASHRAE has published its pioneering consensus-based, code enforceable standard, developed to reduce the risk of infectious aerosol transmission in buildings.

Increased Hospitalizations Involving Fungal Infections during COVID-19 Pandemic, United States, January 2020–December 2021 (Website, Publication)
CDC / Emerging Infectious Diseases
1 July 2023

Gold J, Adjei S, Gundlapalli AV, Huang YA, Chiller T, Benedict K, et al.
COVID-19 infection is a substantial risk factor for certain fungal infections, particularly those caused by invasive molds.

Omicron COVID-19 Case Estimates Based on Previous SARS-CoV-2 Wastewater Load, Regional Municipality of Peel, Ontario, Canada (Website, Publication)
CDC / Emerging Infectious Diseases
28 June 2023

Cheng L, Dhiyebi H, Varia M, Atanas K, Srikanthan N, Hayat S, et al..
At the peak of the Omicron BA.2 outbreak in April 2022, reported COVID-19 cases were underestimated 19-fold because of changes in clinical testing.

Go to Top